Document Detail

Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders.
MedLine Citation:
PMID:  19667978     Owner:  NLM     Status:  In-Process    
There is evidence that some antidepressant drugs are beneficial in the prophylaxis of migraine. Previous reports have shown that migraine patients may respond to various antidepressant agents used for prophylactic therapy. The main purpose of this study was to compare the efficacy of antidepressants from 2 different groups (venlafaxine vs escitalopram) on people who had migraine headache without depression or anxiety. In this prospective study, we evaluated the headache diaries of 93 patients who were being treated with venlafaxine (n = 35) and escitalopram (n = 58). At the end of the 3-month period, patients were reassessed, and those with marked differences in attack frequency, duration, intensity (with visual analog scales), lost work-day equivalent index, and migraine disability assessment questionnaire were compared. There was a clear reduction in headache frequency (P < 0.0001), duration (P < 0.0001), and severity (P < 0.0001) in the venlafaxine group. In addition, there was a significant improvement in daily work performance during headaches (P < 0.0001). In the escitalopram group, monthly headache frequency (P < 0.026), duration (P < 0.002), and intensity (P < 0.027) all decreased significantly, although not to the same extent as with venlafaxine. After the third month of venlafaxine and escitalopram treatment, most of the patients (82.8% vs 96.5%) were seen to have moved to the minimal or infrequent migraine disability assessment group. According to our findings, venlafaxine and escitalopram are both effective in the prophylaxis of migraine headache without depression and anxiety. This effect was independent of mood disorder. Escitalopram should be the first choice because of its fewer side effects, but venlafaxine may be used if escitalopram is found to be insufficient.
Sultan Tarlaci
Related Documents :
19031498 - Lay trainers with migraine for a home-based behavioral training: a 6-month follow-up st...
24386638 - Hippocampal gene expression of deiodinases 2 and 3 and effects of 3,5-diiodo-l-thyronin...
18437408 - The value of herbal medicines in the treatment of acute non-purulent rhinosinusitis. re...
7924238 - Validity of a brief questionnaire in screening asymptomatic subjects from subjects with...
11459378 - Religion as a cross-cultural determinant of depression in elderly europeans: results fr...
23487178 - The effect of physician's 30 s smoking cessation intervention for male medical outpatie...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical neuropharmacology     Volume:  32     ISSN:  1537-162X     ISO Abbreviation:  Clin Neuropharmacol     Publication Date:    2009 Sep-Oct
Date Detail:
Created Date:  2009-10-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7607910     Medline TA:  Clin Neuropharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  254-8     Citation Subset:  IM    
Ozel Ege Sağlik Hastanesi, Nöroloji Bölümü, 35220 Alsancak Izmir, Türkiye.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fluoxetine Blocks Myotonic Runs and Reverts Abnormal Surface Electromyogram Pattern in Patients With...
Next Document:  The effects of apomorphine on visual perception in patients with Parkinson disease and visual halluc...